Скачать или смотреть ISB 2001/ ABBV 2001 - Trispecific Antibody | Therapies on the Horizon

ISB 2001 (ABBV-2001) is a next-generation trispecific antibody being studied for the treatment of multiple myeloma. In this video, we break down how ISB 2001 works, including its unique three-target design that engages BCMA, CD38, and CD3 to redirect T cells toward myeloma cells.

We’ll discuss the science behind trispecific antibodies, how ISB 2001 differs from bispecific therapies, early clinical trial insights, potential benefits, and key safety considerations. As immunotherapy continues to evolve, trispecific antibodies like ABBV-2001 may represent an important step forward for patients with relapsed or refractory myeloma.


If this video has helped you or a loved one, consider donating to HealthTree. Every donation helps us continue to create free and high-quality blood cancer educational content: https://give.healthtree.org/give/6286...

For an organized lesson structure, watch on our site here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!

Patients have the key to find cures for cancer. Learn more about HealthTree's services here: https://healthtree.org/curehub?utm_so...
Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.